Our team has deep expertise in every aspect of cGMP-compliant manufacturing of immunotherapies. We provide a tailored solution, working with your process or one developed for you by our Process Development service. Our comprehensive service offering includes:
Our cGMP facilities in Gainesville, Florida, and Research Triangle Park, North Carolina are equipped with the latest technology platforms, staffed by scientists with deep expertise in immunotherapy development and manufacturing.
We have the capacity to handle manufacturing programs ranging from small runs to volume production to support large, multi-site trials.
Kincell Bio is committed to meeting the highest quality standards throughout the development process. Elements of our robust quality assurance program include:
A dedicated Project Manager ensures your manufacturing program stays on track, at every step. Careful planning up-front is focused on ensuring an efficient production process for your product. Our clinical manufacturing experts are available to answer your questions and address any concerns.
Throughout the manufacturing process, we keep you informed with responsive communication.
Featured news
Kincell Bio has acquired a state-of-the-art manufacturing facility in North Carolina, expanding our network to include late-phase and pivotal capabilities.
“One of the most exciting aspects of working at Kincell Bio is the potential impact it can have on patients’ lives. Knowing that the therapies we’re developing could offer new hope to individuals with difficult-to-treat cancers is incredibly motivating.”
“I look forward to coming to Kincell Bio every day knowing that I’m contributing to the delivery of cutting edge, life changing medications and that I’m regularly going to learn something new along the way.”
